Compugroup Medical Se Stock Current Ratio
| COP Stock | EUR 23.50 0.32 1.34% |
Fundamental analysis of Compugroup Medical allows traders to better anticipate movements in Compugroup Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
Compugroup |
Compugroup Medical SE Company Current Ratio Analysis
Compugroup Medical's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Compugroup Medical SE has a Current Ratio of 0.0 times. This indicator is about the same for the Other average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Compugroup Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Compugroup Medical's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Compugroup Medical could also be used in its relative valuation, which is a method of valuing Compugroup Medical by comparing valuation metrics of similar companies.Compugroup Medical is currently under evaluation in current ratio category among its peers.
Compugroup Fundamentals
| Current Valuation | 2.74 B | |||
| Price To Book | 2.94 X | |||
| Price To Sales | 1.82 X | |||
| Revenue | 1.03 B | |||
| EBITDA | 213.99 M | |||
| Net Income | 68.97 M | |||
| Total Debt | 587.08 M | |||
| Cash Flow From Operations | 165.27 M | |||
| Market Capitalization | 3.3 B | |||
| Total Asset | 1.79 B | |||
| Z Score | 3.0 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 1.79 B | |||
| Last Dividend Paid | 0.5 |
About Compugroup Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Compugroup Medical SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Compugroup Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Compugroup Medical SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Compugroup Stock
Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.